Download our company 'Factsheet' to view further information on the organisation, its products and services.   TAP Company 'Factsheet' (714k)   Historically TAP has been first to market with many of the automated solutions now widely accepted as industry standards. Helping to transform the way pharmaceutical and biotechnology companies orchestrate their drug discovery, bioprocessing and high throughput biology research programmes.   TAP’s systems are designed to reduce drug discovery timelines, resolve process bottlenecks and ultimately give life science organisations significant speed to market advantages.     TAP offers a full range of products and platform technologies plus custom engineering and consultancy services to the life science research market Customers’ applications include; regenerative medicine, cell therapy, biobanking, drug discovery and high throughput screening TAP is a privately owned public limited company, shareholding is split 35% employees, 52% private investors and 13% 3i venture capital Headquarters in Royston near Cambridge UK, plus a sales and support facility in Wilmington Delaware USA Turnover for year ending March 2007 was £21.6m       Back to top   print page